GLP-1 analogs: Satiety without malaise?

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 293, Issue 3, 2007, Pages

  Tang Christensen, Mads ^a   Cowley, Michael A ^b  

^a Rheoscience A/S   (Denmark)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; EXENDIN 4; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; LIRAGLUTIDE; SITAGLIPTIN; VILDAGLIPTIN;

BRAIN STEM; CLINICAL TRIAL; DIABETES MELLITUS; DRUG HALF LIFE; DRUG MECHANISM; EDITORIAL; FOOD INTAKE; GLUCOSE HOMEOSTASIS; HUMAN; HYPOTHALAMUS; INSULIN RELEASE; MALAISE; NAUSEA; NONHUMAN; PICA; PRIORITY JOURNAL; PROTEIN FUNCTION; SATIETY; STOMACH EMPTYING;

ANIMALS; EATING; GLUCAGON-LIKE PEPTIDE 1; HUMANS; MACACA MULATTA; PEPTIDES; RECEPTORS, GLUCAGON; SATIETY RESPONSE; VENOMS;

EID: 34548380799     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00449.2007     Document Type: Editorial

References (18)

1. Bell GI, Santerre RF, Mullenbach GT. Hamster preproglucagon contains the sequence of glucagon and two related peptides. Nature 302: 716-718, 1983.
2. Bullock BP, Heller RS, Habener JF. Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor. Endocrinology 137: 2968-2978, 1996.
3. Combettes MM. GLP-1 and type 2 diabetes: physiology and new clinical advances. Curr Opin Pharmacol 6: 598-605, 2006.
4. Drucker DJ. Glucagon-like peptides. Diabetes 47: 159-169, 1998.
5. Holst JJ. Enteroglucagon. Annu Rev Physiol 59: 257-271, 1997.
6. Larsen PJ, Fledelius C, Knudsen LB, Tang-Christensen M. Systemic administration of the long-acting GLP-1 derivative NN2211 induces lasting and reversible weight loss in both normal and obese rats. Diabetes 50: 2530-2539, 2001.
7. Larsen PJ, Tang-Christensen M, Holst JJ, Orskov C. Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem. Neuroscience 77: 257-270, 1997.
8. Meece J. Pancreatic islet dysfunction in type 2 diabetes: a rational target for incretin-based therapies. Curr Med Res Opin 23: 933-944, 2007.
9. Merchenthaler I, Lane M, Shughrue P. Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system. J Comp Neurol 403: 261-280, 1999.
10. Pratley RE, Salsali A. Inhibition of DPP-4: a new therapeutic approach for the treatment of type 2 diabetes. Curr Med Res Opin 23: 919-931, 2007.
11. Rinaman L. A functional role for central glucagon-like peptide-1 receptors in lithium chloride-induced anorexia. Am J Physiol Regul Integr Comp Physiol 277: R1537-R1540, 1999.
12. Rinaman L. Interoceptive stress activates glucagon-like peptide-1 neurons that project to the hypothalamus. Am J Physiol Regul Integr Comp Physiol 277: R582-R590, 1999.
13. Scott KA, Moran TH. The GLP-1 agonist exendin-4 reduces food intake in nonhuman primates through changes in meal size. Am J Physiol Regul Integr Comp Physiol (June 20, 2007); doi:10.1152/ajpregu.00323.2007.
14. Tang-Christensen M, Larsen PJ, Goke R, Fink-Jensen A, Jessop DS, Moller M, Sheikh SP. Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats. Am J Physiol Regul Integr Comp Physiol 271: R848-R856, 1996.
15. Thiele TE, Van Dijk G, Campfield LA, Smith FJ, Burn P, Woods SC, Bernstein IL, Seeley RJ. Central infusion of GLP-1, but not leptin, produces conditioned taste aversions in rats. Am J Physiol Regul Integr Comp Physiol 272: R726-R730, 1997.
16. Turton MD, O'Shea D, Gunn I, Beak SA, Edwards CM, Meeran K, Choi SJ, Taylor GM, Heath MM, Lambert PD, Wilding JP, Smith DM, Ghatei MA, Herbert J, Bloom SR. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 379: 69-72, 1996.
17. Van Dijk G, Thiele TE. Glucagon-like peptide-1 (7-36) amide: a central regulator of satiety and interoceptive stress. Neuropeptides 33: 406-414, 1999.
18. Wajchenberg BL. β-Cell failure in diabetes and preservation by clinical treatment. Endocr Rev 28: 187-218, 2007.